TGFB1 and cardiac hypertrophy: In a rat model of TAC, cardiac fibrosis was mitigated via muscle-specific LSD1 knockout, resulting in the inhibition of the TGF-β signaling pathway and the attenuation of systolic dysfunction, cardiac hypertrophy, and fibrosis [112].